Uhlmann Price Securities, LLC Tekla Life Sciences Investors Transaction History
Uhlmann Price Securities, LLC
- $140 Billion
- Q2 2025
A detailed history of Uhlmann Price Securities, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Uhlmann Price Securities, LLC holds 61,711 shares of HQL stock, worth $1.01 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
61,711
Previous 70,943
13.01%
Holding current value
$1.01 Million
Previous $900 Million
12.19%
% of portfolio
0.56%
Previous 0.66%
Shares
4 transactions
Others Institutions Holding HQL
# of Institutions
86Shares Held
9.51MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.02MShares$49.3 Million0.99% of portfolio
-
Penserra Capital Management LLC Orinda, CA770KShares$12.6 Million0.14% of portfolio
-
Morgan Stanley New York, NY766KShares$12.5 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A6451KShares$7.38 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY431KShares$7.04 Million0.23% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...